ADGM: ADAGIO MEDICAL HOLDINGS INC Stocks News on June 6, 2025

ADGM

Business Wire

22 days ago

Adagio Medical Reports First Quarter 2025 Results

ADGM

Business Wire

a month ago

Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

ADGM

Business Wire

2 months ago

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

ADGM

Business Wire

2 months ago

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

ADGM

Business Wire

2 months ago

Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

Adagio Medical Holdings Reports Full Year 2024 Earnings

ADGM

Simply Wall St.

2 months ago

Adagio Medical Holdings Reports Full Year 2024 Earnings

ADGM

Business Wire

3 months ago

Adagio Medical Provides Clinical and Business Updates

ADGM

Business Wire

3 months ago

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

ADGM

Business Wire

4 months ago

Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference

ADGM

Business Wire

6 months ago

Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director

Adagio Medical Holdings Reports Third Quarter 2024 Earnings

ADGM

Simply Wall St.

7 months ago

Adagio Medical Holdings Reports Third Quarter 2024 Earnings

ADGM

Business Wire

7 months ago

Adagio Medical Reports Third Quarter 2024 Results

ADGM

Business Wire

7 months ago

Adagio Medical to Present at the Stifel 2024 Healthcare Conference

ADGM

Business Wire

7 months ago

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

ADGM

Business Wire

8 months ago

Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias

ADGM

Business Wire

10 months ago

Latest ADAGIO MEDICAL HOLDINGS INC (ADGM) News on June 6, 2025

Adagio Medical Reports First Quarter 2025 Results

Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

Adagio Medical Holdings Reports Full Year 2024 Earnings

Adagio Medical Provides Clinical and Business Updates

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference

Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director

Adagio Medical Holdings Reports Third Quarter 2024 Earnings

Adagio Medical Reports Third Quarter 2024 Results

Adagio Medical to Present at the Stifel 2024 Healthcare Conference

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias

Adagio Medical Provides Business Updates

Share on Social Networks: